Vincenzo Cuomo

Author PubWeight™ 69.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2002 7.72
2 Gender differences in drug responses. Pharmacol Res 2006 2.50
3 Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. Exp Neurol 2007 1.85
4 Propofol enhances memory formation via an interaction with the endocannabinoid system. Anesthesiology 2011 1.76
5 Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A 2009 1.75
6 Transport infrastructure surveillance and monitoring by electromagnetic sensing: the ISTIMES project. Sensors (Basel) 2010 1.60
7 Comparative evaluation of simple indices of insulin resistance. Metabolism 2004 1.42
8 Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 2006 1.28
9 Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proc Natl Acad Sci U S A 2009 1.25
10 The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Int Rev Neurobiol 2009 1.20
11 Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 2009 1.17
12 Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology (Berl) 2005 1.15
13 Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr Metab Cardiovasc Dis 2006 1.14
14 Anandamide hydrolysis: a new target for anti-anxiety drugs? Trends Mol Med 2003 1.11
15 Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide. Am J Physiol Endocrinol Metab 2013 1.07
16 Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A 2003 1.05
17 The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci 2010 1.04
18 Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. Int Rev Neurobiol 2009 1.04
19 The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons. Peptides 2013 1.02
20 Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev 2004 1.02
21 Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J Neurosci 2012 1.00
22 Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress. Antioxid Redox Signal 2013 0.98
23 CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons. Neurosci Lett 2006 0.98
24 Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats. Neuropsychopharmacology 2002 0.96
25 Cannabis and the developing brain: insights from behavior. Eur J Pharmacol 2008 0.95
26 The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J Neurosci 2010 0.95
27 Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex 2005 0.94
28 Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl) 2010 0.93
29 Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats. Addict Biol 2007 0.92
30 Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsychopharmacol 2006 0.91
31 Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl) 2008 0.88
32 Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol Aging 2011 0.88
33 Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology (Berl) 2010 0.87
34 Novelty-induced emotional arousal modulates cannabinoid effects on recognition memory and adrenocortical activity. Neuropsychopharmacology 2013 0.86
35 Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments. Neuropharmacology 2011 0.86
36 The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front Behav Neurosci 2012 0.85
37 Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex. Neuropharmacology 2007 0.83
38 Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. Front Behav Neurosci 2012 0.83
39 Developmental exposure to methylmercury elicits early cell death in the cerebral cortex and long-term memory deficits in the rat. Int J Dev Neurosci 2008 0.83
40 Prenatal exposure to carbon monoxide affects postnatal cellular electrophysiological maturation of the rat heart: a potential substrate for arrhythmogenesis in infancy. Circulation 2004 0.82
41 Delta(9)-tetrahydrocannabinol increases endogenous extracellular glutamate levels in primary cultures of rat cerebral cortex neurons: involvement of CB(1) receptors. J Neurosci Res 2002 0.82
42 The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat. Brain Res 2004 0.82
43 Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochem Res 2009 0.82
44 Cognitive impairment and increased brain neurosteroids in adult rats perinatally exposed to low millimolar blood alcohol concentrations. Psychoneuroendocrinology 2007 0.81
45 Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol. Toxicol Appl Pharmacol 2007 0.81
46 Olfactory memory is impaired in a triple transgenic model of Alzheimer disease. Behav Brain Res 2011 0.81
47 Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int J Pharm 2011 0.80
48 Relationship between plasma insulin and left ventricular mass in normotensive participants of the Gubbio Study. Clin Endocrinol (Oxf) 2003 0.80
49 Chronic nandrolone administration induces dysfunction of the reward pathway in rats. Steroids 2014 0.79
50 Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked [3H]GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety. J Pharmacol Exp Ther 2009 0.79
51 WAG/Rij rats show a reduced expression of CB₁ receptors in thalamic nuclei and respond to the CB₁ receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges. Epilepsia 2010 0.79
52 Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. Pharmacol Res 2009 0.79
53 Modulatory activity of soluble beta amyloid on HPA axis function in rats. Curr Pharm Des 2014 0.79
54 Social play behavior, ultrasonic vocalizations and their modulation by morphine and amphetamine in Wistar and Sprague-Dawley rats. Psychopharmacology (Berl) 2013 0.78
55 Neurochemical consequence of steroid abuse: stanozolol-induced monoaminergic changes. Steroids 2011 0.77
56 Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study. Pharmacol Res 2007 0.77
57 The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment. Semin Nephrol 2004 0.77
58 Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes. Int J Epidemiol 2005 0.77
59 Prenatal exposure to carbon monoxide delays postnatal cardiac maturation. Lab Invest 2010 0.77
60 CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor. CNS Drug Rev 2002 0.76
61 Prenatal methylmercury exposure: effects on stress response during active learning. Bull Environ Contam Toxicol 2008 0.76
62 Prenatal exposure to carbon monoxide temporarily impairs maturation of rat cardiomyocytes: Electrophysiological evidence. Exp Clin Cardiol 2005 0.75
63 The contribution of transgenic and nontransgenic animal models in Alzheimer's disease drug research and development. Behav Pharmacol 2017 0.75
64 Exploiting quartz spectral signature for the detection of cloud-affected satellite infrared observations over African desert areas. Appl Opt 2004 0.75
65 Retrieval of foreign-broadened water vapor continuum coefficients from emitted spectral radiance in the H2O rotational band from 240 to 590 cm(-1). Opt Express 2008 0.75
66 Breadboard of a Fourier-transform spectrometer for the radiation explorer in the far infrared atmospheric mission. Appl Opt 2005 0.75
67 Interferometer for ground-based observations of emitted spectral radiance from the troposphere: evaluation and retrieval performance. Appl Opt 2008 0.75